Cipla Limited

BSE : 500087 | NSE : CIPLA

Industry : Pharmaceuticals | ISIN : INE059A01026 | FreeFloat : 66.01% | FnO : Yes | LotSize : 650


Intellectual Capital (IC)38,026.59
Net Worth (NW)21,117.38
Intrinsic Worth (IW)59,143.97
Market Cap (MC)82,137.70
Economic Value Added-205.17
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)64.29%
IC Gross Margin (EBITDA/IC)12.56%
IC Net Margin (NPT/IC)7.99%
Knowledge Turnover (Sales/IC)0.59
Market to Intrinsic Value (MC/IW)1.39

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 733.06Rs. 1,018.05
26 May 2022 ---- Rs. 964.55
-7.30     -0.76%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 955.64ReduceSell
KB > 50% : Yes50 DMA : Rs. 992.97
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
3989.02
4067.39
983.01
715.01
662.89
478.19
446.87
Sep-19
C
4395.78
4496.30
1010.02
727.06
680.99
474.50
382.48
Dec-19
C
4371.00
4443.13
830.46
552.57
506.40
339.38
544.23
Mar-20
C
4376.19
4469.37
726.70
380.90
327.90
238.49
-3.46
Jun-20
C
4346.16
4411.61
1114.19
845.21
799.21
566.04
629.31
Sep-20
C
5038.29
5091.76
1230.04
964.98
925.65
659.35
629.40
Dec-20
C
5168.69
5255.63
1317.82
1069.39
1021.47
751.61
948.81
Mar-21
C
4606.45
4666.58
856.37
571.18
543.73
411.51
379.94
Jun-21
C
5504.35
5569.28
1286.20
1025.09
995.52
709.92
886.88
Sep-21
C
5519.80
5580.47
1286.87
1033.81
995.81
709.15
613.03
Dec-21
C
5478.86
5570.15
1322.26
1074.79
1054.11
756.88
682.85
Mar-22
C
5260.33
5324.35
807.72
517.41
499.31
370.70
636.02
* C - Consolidated, S - Standalone